The effect of statin use on cognition in Parkinson’s disease
Objective: To evaluate the effect of statin (HMG CoA reductase inhibitor) use on 1) baseline cognition; 2) rate of cognitive decline; and 3) conversion from…Baseline physical activity may influence exercise-induced changes in cognitive function in Parkinson’s disease
Objective: To determine how physical activity (PA) levels influence disease severity and cognitive function changes as a result of exercise in Parkinson's disease (PD). Background:…Self-reported cognitive complaints and neuropsychological performance in idiopathic REM sleep behavior disorder
Objective: The aim of this study was to investigate self-reported cognitive complaints in idiopathic REM sleep behavior disorder (iRBD) in link with the presence of…Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study
Objective: Outcome of Rivastigmine treatment in Parkinson's disease Dementia (PDD). Effect of treatment on cognition and Neuropsychiatric symptoms. To compare clinical global impression of Clinicians…Impairment of decision-making processes in patients with Parkinson’s disease during a strategic game
Objective: To characterize differences in choice patterns, and differentiate the effects of dopaminergic (DA) treatment on motor and cognitive function, during dynamic decision-making in Parkinson's…Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA
Objective: Analysing the relationship between the polymorphisms of ApoE gene and cognitive performance of patients with Parkinson's disease. Background: Cognitive impairment is a common clinical…How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study
Objective: (1) To ascertain the evolution of neuropsychological profile of PD patients with stable cognition (non-converter) in comparison to PD patients with a decline (converters)…Attention and dopamine: Increased distractibility in Parkinson’s disease
Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…Does repetitive transcranial magnetic stimulation (rTMS) affect cognitive function in Parkinson’s disease by modulating high-frequency brain oscillations: A magnetoencephalography (MEG) study
Objective: To better understand the mechanisms of how repetitive transcranial magnetic stimulation (rTMS) may improve cognitive function in Parkinson's disease (PD). Background: Cognitive dysfunction and…Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination
Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment. Background: The DRS-II, a screening…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.